Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

A new mouse model effectively mimics vitiligo for research and drug testing.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

New treatments focusing on immune pathways show promise for stubborn hair loss.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Dental care may help improve hair loss in alopecia patients.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Vitamin A affects hair loss and immune response in alopecia areata.

Testosterone's effects on COVID-19 are unclear and need more research.

New medications could improve treatment for severe alopecia areata in Australia.

COVID-19 may trigger hair loss conditions like alopecia areata.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Tph cells are linked to the severity of systemic lupus erythematosus.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

PRP is an effective and safe treatment for alopecia areata.